|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A01N 37/18 | (2006.01) |
| C07C 233/00 | (2006.01) | ||
| A61K 31/165 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 17/02 | (2006.01) | ||
| A61P 19/00 | (2006.01) |
| (11) | Number of the document | 2425715 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11185780.1 |
| Date of filing the European patent application | 2006-08-28 | |
| (97) | Date of publication of the European application | 2012-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-05 |
| (46) | Date of publication of the claims translation | 2014-07-25 |
| (30) | Number | Date | Country code |
| 712390 P | 2005-08-31 | US |
| (72) |
Dalton, James T, US
Miller, Duane D., US
|
| (73) |
University of Tennessee Research Foundation,
1534 White Avenue, Suite 403, Knoxville, TN 37996-1527,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Inkstų ligos simptomų gydymas selektyviais androgeno receptorių moduliatoriais (SARM) |
| Treating symptoms of renal disease with selective androgen receptor modulators (SARM) |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-08-28 |